Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Assure Holdings Corp IONM

Assure Holdings Corp. is a provider of outsourced intraoperative neurophysiological monitoring (IONM) and remote neurology services. The Company delivers a suite of clinical and operational services to support surgeons and medical facilities during invasive procedures. Its IONM tool is used for various surgical verticals, such as neurosurgery, spine, ear, nose, and throat, and other surgical procedures. Its in-house interoperative neurophysiologists (INP) provide the technical component IONM services from the operating room throughout the procedure, while telehealth-oriented supervising practitioners provide a level of redundancy and risk mitigation in support of the onsite INPs and the surgical team. It offers IONM services, including scheduling the INP and supervising practitioner, real-time monitoring, patient advocacy and subsequent billing for services provided. During each procedure, it provides two types of services, the Technical Component and Professional Component of IONM.


OTCQB:IONM - Post by User

Bullboard Posts
Post by Stuatoron Apr 26, 2019 11:52am
198 Views
Post# 29675004

Financials

FinancialsComparisons:

Case Volume:
2017 - 1562    2018 - 2799   2019E - 5000 
INCREASE - 79%.  ESTIMATED GROWTH: 79%

Revenues:
Revised 2017 - 15.8M      Revised 2018 - 14.8M
DOWN - 7%

Gross Margins:
Revised 2017 - 83.4%      Revised 2018 - 76%
DOWN - 7.4%

EBITDA:
Revised 2017 - 12M      Revised 2018 - 6.7M
DOWN - 44%

Net Income:
Revised 2017 - 10.5M (without the significant share charge)      Revised 2018 - 6.7M
DOWN - 36%

Share Price:
2018:  ~$1.50.    2019: ~$1.20
DOWN - 20%

If the shares are to be valued similar to that in 2018, as stated previously, I would expect another 15-30% loss due to the massive reduction in profitability.  Also, with the missteps from previous years (CEO/CFO misappropriating funds & bad debt adjustment), it isn't unreasonable to expect more issues going forward.  And therefore it deserves a discounted price.

PRICE TARGET - $0.90

Stuator
Bullboard Posts